Female Sexual Interest Arousal Disorder
📧 Sign up to get email alerts when something new happens for Female Sexual Interest Arousal Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Transdermal Testosterone Gel for Female Sexual Interest and Arousal Disorder in Peri- and Post Menopause [NA]
Clinical trial update on transdermal testosterone gel for female sexual interest/arousal disorder in peri- and postmenopausal women; the stu…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Effects of Ospemifene on Brain Activation Patterns in Women With Sexual Interest-arousal Disorders [Phase 4]
Phase 4 trial evaluating the effects of ospemifene on brain activation patterns in women with female sexual interest/arousal disorder. The s…
-
CLINICAL_TRIALS trial_result · 2025-09-03Clinical Trial Update: Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women [Phase 2]
Phase 2 trial completed evaluating estetrol for female sexual arousal disorder in postmenopausal women.
-
CLINICAL_TRIALS trial_result · 2024-12-13Clinical Trial Update: Randomized Comparison of Mindfulness Versus Group Support for Treatment of Low Sexual Desire in Women [NA]
This randomized trial comparing mindfulness to group support for low female sexual desire in women has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Study of Pharmacological Treatment in Women With Female Sexual Interest/Arousal Disorder (FSIAD). [Phase 3]
Phase 3 clinical trial update investigating a pharmacological treatment for female sexual interest/arousal disorder (FSIAD) in women; curren…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Group Psychoeducational Treatment for Women With Sexual Arousal Difficulties, Phase II [NA]
This clinical trial update notes the completion of a Phase II study evaluating a group psychoeducational treatment for women with sexual aro…
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: 12 Week Safety Trial of Flibanserin in Depressed Women Taking an SSRI or SNRI With Decreased Sexual Desire and Distress [Phase 3]
A Phase 3 safety trial evaluating flibanserin (Addyi) in depressed women taking an SSRI or SNRI with decreased sexual desire and distress wa…